Invited
Speaker
Emerging Trends in the Discovery and Development of Chemical
Probes against Novel Therapeutic Targets in Academia: A Mount Everest
in the Making
Rathnam Chaguturu
USA
Academia has historically been involved in exploring the
fundamental aspects of disease targets and in developing ‘probe’
molecules to gain a better understanding of the biochemical basis
of new and novel therapeutic targets. This has been particularly true
in developing countries. Probe discovery has now gained unprecedented
momentum in academia with the availability of vendor-supplied, diversity-based,
chemical libraries, and an easy and ready access to on-campus high
throughput screening (HTS) laboratories or liquid handling robotic
instrumentation. Academic researchers, who long held the view that
HTS is an anti-intellectual endeavor, have been experiencing a change
of mind-set, and have since come to appreciate the strength of HTS
in chemical probe discovery. The challenge that remains to be addressed
by academia is in defining the end goal of HTS: is it just to find
a ‘tool’ molecule, or is it to discover and develop a
‘drug’? What processes and collaborations have been set
in place to transform a hit to a probe to a lead? With the ‘publish
or perish’ dogma that is prevalent in academia, protection of
intellectual property rights is a formidable task even if one finds
the proverbial ‘needle in a haystack’. Technology transfer
offices in academia continue to experience difficulty in licensing
these molecular probes to pharma during these very early stages of
medicinal chemistry explorations. A better understanding of the changing
landscape at the pharma-academia interface, the role of academia in
translational research and what constitutes a win-win scenario for
technology transfer, is needed to strengthen opportunities for close
collaboration between Pharma and Academia. The University of Kansas
experience in HTS-based discovery and development of tool molecules
will be discussed to highlight the strengths of molecular probe discovery
in academia, and how it applies to the academia in the developing
world.
|